Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M30,955Revenue $M9,766Net Margin (%)1.0Altman Z-Score0.7
Enterprise Value $M62,104EPS $1.8Operating Margin %17.3Piotroski F-Score6
P/E(ttm)64.9Beneish M-Score-2.1Pre-tax Margin (%)1.1Higher ROA y-yN
Price/Book5.510-y EBITDA Growth Rate %10.5Quick Ratio1.3Cash flow > EarningsY
Price/Sales4.75-y EBITDA Growth Rate %55.9Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow18.0y-y EBITDA Growth Rate %36.3ROA % (ttm)0.2Higher Current Ratio y-yY
Dividend Yield %--PEG1.2ROE % (ttm)1.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M343ROIC % (ttm)-13.3Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXLou Simpson 2015-12-31 Add2.51%$70.32 - $182.32
($111.15)
$ 96.59-13%Add 38.18%2,698,614
VRXKen Fisher 2015-12-31 Sold Out $70.32 - $182.32
($111.48)
$ 96.59-13%Sold Out0
VRXLeon Cooperman 2015-09-30 Buy 1.75%$158.08 - $262.52
($233.19)
$ 96.59-59%New holding484,915
VRXSteve Mandel 2015-09-30 Add1.62%$158.08 - $262.52
($233.19)
$ 96.59-59%Add 40.52%7,461,780
VRXLou Simpson 2015-09-30 Add1.35%$158.08 - $262.52
($233.19)
$ 96.59-59%Add 13.00%1,952,983
VRXGlenn Greenberg 2015-09-30 Reduce-0.79%$158.08 - $262.52
($233.19)
$ 96.59-59%Reduce -2.16%5,577,892
VRXWallace Weitz 2015-09-30 Reduce-0.54%$158.08 - $262.52
($233.19)
$ 96.59-59%Reduce -12.08%630,155
VRXChris Davis 2015-09-30 Reduce-0.2%$158.08 - $262.52
($233.19)
$ 96.59-59%Reduce -14.36%1,509,122
VRXPrivate Capital 2015-09-30 Reduce-0.14%$158.08 - $262.52
($233.19)
$ 96.59-59%Reduce -1.91%296,931
VRXJohn Paulson 2015-09-30 Reduce-0.12%$158.08 - $262.52
($233.19)
$ 96.59-59%Reduce -1.22%8,890,000
VRXJoel Greenblatt 2015-09-30 Add0.05%$158.08 - $262.52
($233.19)
$ 96.59-59%Add 44.95%88,677
VRXRuane Cunniff 2015-09-30 Add0.03%$158.08 - $262.52
($233.19)
$ 96.59-59%Add 0.11%33,922,192
VRXGeorge Soros 2015-09-30 Sold Out -0.02%$158.08 - $262.52
($233.19)
$ 96.59-59%Sold Out0
VRXKen Fisher 2015-09-30 Add$158.08 - $262.52
($233.19)
$ 96.59-59%Add 0.27%1,833
VRXJohn Paulson 2015-06-30 Add7.33%$197.39 - $241.73
($221.34)
$ 96.59-56%Add 339.02%9,000,000
VRXLou Simpson 2015-06-30 Reduce-1.16%$197.39 - $241.73
($221.34)
$ 96.59-56%Reduce -8.97%1,728,265
VRXWallace Weitz 2015-06-30 Reduce-1.08%$197.39 - $241.73
($221.34)
$ 96.59-56%Reduce -21.86%716,730
VRXGlenn Greenberg 2015-06-30 Reduce-1.07%$197.39 - $241.73
($221.34)
$ 96.59-56%Reduce -2.99%5,701,010
VRXSteve Mandel 2015-06-30 Reduce-0.2%$197.39 - $241.73
($221.34)
$ 96.59-56%Reduce -4.66%5,310,143
VRXRuane Cunniff 2015-06-30 Reduce-0.19%$197.39 - $241.73
($221.34)
$ 96.59-56%Reduce -0.60%33,884,050
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pearson J. MichaelCEO 2015-11-05Sell1,297,399$78.4823.08view
Farmer Ronald HaroldDirector 2015-10-21Buy1,500$181.6-46.81view
Farmer Ronald HaroldDirector 2015-08-26Buy500$220-56.1view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.97-57.07view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-62.01view
Rosiello Robert L.Executive Vice President 2015-06-12Buy12,900$232.51-58.46view
UBBEN JEFFREY W 2015-06-10Sell4,200,000$220.24-56.14view
Farmer Ronald HaroldDirector 2015-06-09Buy1,000$260.63-62.94view
Mirovsky PavelEVP, Pres. & GM Valeant EMENA 2015-06-02Sell38,000$238.01-59.42view
Whitaker Anne ClemDirector 2015-05-26Buy7,500$234.67-58.84view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
So, Bill Ackman Makes Some Good Points on the Index Bubble… Feb 05 2016 
Valeant's Share Price Continues to Decline Feb 05 2016 
Whitney Tilson's New Emails to Partners Feb 05 2016 
Leith Wheeler Investment Funds 4th Quarter Review Jan 29 2016 
Pershing Square's New Presentation, Part 1 Jan 29 2016 
Steven Romick Reduces 7 Stakes in 4th Quarter Jan 28 2016 
Bill Ackman Comments on Valeant Jan 27 2016 
Bill Ackman's Pershing Square Annual Investor Letter Jan 27 2016 
Wallace Weitz Comments on Valeant Pharmaceuticals Jan 22 2016 
Share Your Year-End Performance, Best Picks for 2016 Jan 06 2016 

More From Other Websites
Congress unites in scorn for Shkreli, but gridlock remains Feb 05 2016
Congress unites in scorn for Shkreli, but gridlock remains Feb 05 2016
The Real Lesson of the Shkreli Circus Feb 05 2016
Valeant's Share Price Continues to Decline Feb 05 2016
Shkreli theatrical display misses core biotech pricing issues Feb 05 2016
CRI Advanced Hound Partners in January. VRX dragged Feb 05 2016
So, Bill Ackman Makes Some Good Points on the Index Bubble... Feb 05 2016
[$$] Valeant Needs More Volume Amid the Noise Feb 05 2016
[$$] Martin Shkreli Pleads the Fifth Before Congress Feb 05 2016
[$$] Martin Shkreli Takes the Fifth Before Congress Feb 04 2016
After The Martin Shkreli Circus, How Can We Fix Drug Pricing? Feb 04 2016
[$$] Valeant Needs More Volume Amid the Noise Feb 04 2016
Rep. John Mica: Shkreli Was Arrogant Feb 04 2016
It’s Time to Buy This Biotech Gem Feb 04 2016
Shkreli, Valeant Go To Washington -- Recap Feb 04 2016
Smirks, silence and nerves: Recap of the drug pricing hearing with Shkreli Feb 04 2016
How Martin Shkreli Is ‘Trashing’ the Pharma Industry Feb 04 2016
TW Drove ValueAct’s Performance in January. VRX did not Feb 04 2016
Expectations for Valeant Pharmaceuticals in 2016 Feb 04 2016
Valeant, Turing Slammed as Shkreli Calls Congress ‘Imbeciles’ Feb 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK